Metastatic Prostatic Adenocarcinoma in an Inguinal Hernia Sac in a Patient with Undetectable Serum Prostate Specific Antigen Level  by Chung, Shiu-Dong et al.
J Formos Med Assoc | 2007 • Vol 106 • No 5 397
CASE REPORT
Metastasis within hernia sac contents is an infre-
quent clinical finding, with a reported incidence
of 0.07%.1 The discovery of a metastatic tumor in
an inguinal hernia sac generally suggests advanced
disease and a short life expectancy in these pa-
tients. The metastasis of prostate cancer to hernia
contents is extremely rare and only five such cases,
including four cases identified in the pre-prostate
specific antigen (PSA) era with inadequate clini-
cal details, have been reported in the English-
language literature.1,2 The remaining one case
reported in the PSA era had overt cancer nodule
embedded in the hernia sac with a very high
serum PSA level (> 100 ng/mL).3
A distant metastasis or local recurrence of
prostate cancer in the absence of serum PSA ele-
vation was only sporadically reported in the lit-
erature.4–10 The explanation for recurrent disease
with undetectable PSA is speculative. Possible rea-
sons include histologic and biochemical dedif-
ferentiations and unrecognized hypogonadism.5
Case Report
A 64-year-old man presented with painless gross
hematuria in April 1996. The digital rectal exam-
ination revealed a hard nodule at the left lobe of
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Metastatic prostate cancer found within the hernia sac contents is a rare clinical manifestation. We report
a 64-year-old male patient who presented with rare clinical features of prostate cancer. A focal metastasis of
prostate cancer was incidentally found in an incised inguinal hernia sac 5 years after radical prostatectomy.
The serum prostate specific antigen (PSA) level remained undetectable (< 0.01 ng/mL) prior to herniorrha-
phy without any adjuvant therapy. In addition, serial studies performed right after herniorrhaphy disclosed
no evidence of overt clinical metastasis. However, his serum PSA level started rising 12 months later and
bladder invasion as well as a mass in the cul-de-sac was identified subsequently. The serum PSA level was
2.45 ng/mL at his latest visit, which was 5 years after herniorrhaphy. This case implies that physicians
should be more alert in patients with a low preoperative serum PSA level during the period of follow-up.
Both serum PSA and digital rectal examination may be important in patients with low preoperative PSA
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the prostate and needle biopsies revealed a Gleason
score 3 + 4 = 7 adenocarcinoma. The initial serum
PSA level was 1.5 ng/mL (Abbott Architect sys-
tem, USA). He then underwent radical retropubic
prostatectomy in May 1996. Pathologic grading
and staging were Gleason score 3 + 4 = 7 and
pT3bN0M0 (left seminal vesicle invasion and neg-
ative surgical margins). At 2-month postopera-
tive follow-up, serum PSA was undetectable
(< 0.01 ng/mL) and adjuvant therapy was hence
not offered. Follow-up visits were requested every
3 months postoperatively. He remained asymp-
tomatic with an undetectable serum PSA level
(< 0.01 ng/mL) until April 2001, when he pre-
sented with a right inguinal hernia and hernior-
rhaphy was performed. The hernia was an indirect
type with no adhesion of bowel contents. Patho-
logic examination of the transected sac incidentally
disclosed a small area with nests of neoplastic
glands within the fibroconnective tissue (Figure 1).
These tumor cells were immunoreactive to PSA
(Figure 2). He then underwent a thorough metasta-
tic survey, which did not reveal any evidence of 
osseous, visceral or lymph node metastases.
Although the serum PSA level still remained un-
detectable after operation, it became detectable
12 months later and elevated insidiously to
0.51 ng/mL 28 months following herniorrhaphy.
Then we added anti-androgen therapy with cypro-
terone acetate (50 mg) three times daily. Serial
imaging studies still revealed no evidence of clin-
ical metastasis. The following nadir PSA level was
0.11 ng/mL. He presented to us with an episode
of gross hematuria in May 2005 (60 months fol-
lowing herniorrhaphy). Cystoscopic examination
disclosed a tumor at the left lateral wall of the
urinary bladder and pathologic examination of
the resected tissue revealed metastatic prostate
adenocarcinoma. Subsequent computed tomog-
raphy showed a soft tissue nodule, about 2.5 cm
in size in the cul-de-sac region. There was no evi-
dence of osseous or visceral metastasis. After a
combined anti-androgen (cyproterone acetate)
and salvage external beam radiotherapy (60 Gy)
to the true pelvis, the serum PSA level declined
from 2.8 to a nadir level of 0.1 ng/mL 6 months
later. However, the serum PSA level started to 
rise afterwards regardless of continuing anti-
androgen therapy. His serum PSA level was
2.45 ng/mL and testosterone level was 2.62 ng/mL
at the latest visit, which was exactly 5 years 
after herniorrhaphy and 10 years after radical
prostatectomy.
Discussion
The finding of metastatic prostate cancer in an in-
cised hernia sac is extremely rare and the reported
cases presented either with apparently abnormal
finding in the hernia contents or with very high
serum PSA level.3 Our case is unique as the serum
PSA level was undetectable when hernia metasta-
sis was found and no overt metastasis to other
Figure 1. A small area of neoplastic glands (arrow) is found
in the hernia sac tissue (hematoxylin and eosin, 40×).
Figure 2. Strong prostate specific antigen (PSA) cytoplas-
mic immunoreactivity is demonstrated in the metastatic
prostate adenocarcinoma (ABC method, 400×).
Metastatic prostatic adenocarcinoma in an inguinal hernia sac
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organs could be detected. Furthermore, unlike the
common thought that the discovery of a metastatic
tumor in an inguinal hernia sac suggests advanced
disease and a short life expectancy,1 our patient
remained alive 5 years after herniorrhaphy.
The route of metastasis in this case is unclear.
Presumably, the tumor might have metastasized
to the hernia sac via hematogenous dissemination,
which would suggest that other sites of metastases
might also have existed but remained occult. As
the inguinal hernia developed 5 years after radical
prostatectomy, it is less likely that the tumor cells
were spilled over the peritoneum during radical
prostatectomy or had reached the hernia sac via
localized spread.6,7
Distant metastasis from prostate cancer after
radical surgery accompanied by undetectable PSA
is also very rare and a possible explanation for this
phenomenon remains speculative.5,8,9 We could
not exclude the possibility of histologic and bio-
chemical dedifferentiations, given the low pre-
operative serum PSA level (1.5 ng/mL) and high
grade (Gleason score, 3+4=7) in our case. It is
also likely that the small occult lesion found
within the hernia sac might not be able to produce
enough PSA to reach a detectable serum level. The
prognosis of such cases is not predictable based on
the limited reported experience.10 Our patient re-
mained alive 10 years after radical prostatectomy.
In summary, our case is the first one of metasta-
tic prostate cancer found in the hernia sac with an
undetectable serum PSA level. Whatever the mech-
anism accounting for this finding, a detectable
serum PSA level was found eventually and overt
distant metastasis developed. Apart from its rarity,
the case implies that physicians should be more
alert in patients with a low preoperative serum
PSA level during the period of follow-up, as even
a minor elevation of serum PSA level may indicate
a significant distant metastasis. The follow-up
protocol for patients who have undergone radical
prostatectomy includes not only serum PSA but
also digital rectal examination. For patients with
low preoperative PSA level, serum PSA alone is
not an ideal tool for active surveillance.
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